0001209191-21-006433.txt : 20210201 0001209191-21-006433.hdr.sgml : 20210201 20210201161623 ACCESSION NUMBER: 0001209191-21-006433 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210128 FILED AS OF DATE: 20210201 DATE AS OF CHANGE: 20210201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hallock Robert Jason CENTRAL INDEX KEY: 0001829633 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39160 FILM NUMBER: 21576881 MAIL ADDRESS: STREET 1: C/O SOC TELEMED STREET 2: 1768 BUSINESS CENTER DRIVE, SUITE 100 CITY: RESTON STATE: VA ZIP: 20190 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOC Telemed, Inc. CENTRAL INDEX KEY: 0001791091 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 843131208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1768 BUSINESS CENTER DRIVE STREET 2: SUITE 100 CITY: RESTON STATE: VA ZIP: 20190 BUSINESS PHONE: 866-483-9690 MAIL ADDRESS: STREET 1: 1768 BUSINESS CENTER DRIVE STREET 2: SUITE 100 CITY: RESTON STATE: VA ZIP: 20190 FORMER COMPANY: FORMER CONFORMED NAME: Healthcare Merger Corp. DATE OF NAME CHANGE: 20191015 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-28 0 0001791091 SOC Telemed, Inc. TLMD 0001829633 Hallock Robert Jason C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190 0 1 0 0 Chief Medical Officer Class A Common Stock 2021-01-28 4 A 0 88670 0.00 A 88670 D Performance-based Restricted Stock Units 2021-01-28 4 A 0 59113 0.00 A 2024-08-15 Class A Common Stock 59113 59113 D Represents restricted stock units, each of which represents a contingent right to receive one share of the Issuer's Class A Common Stock, of which 1/4th will vest on February 15 of each of 2022, 2023, 2024 and 2025, respectively, subject to the continuous service of the Reporting Person on each vesting date. Each performance-based restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. The PRSUs generally vest in three equal installments on February 15 of each of 2022, 2023 and 2024, respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 20 trading days during any 30 consecutive day period from the date of grant. If the applicable performance goals have not been achieved by August 15, 2024, all unvested PRSUs will be forfeited. /s/ Eunice Kim, as Attorney-in-Fact 2021-02-01